14C-ARN-509 Microtracer Label AME and Absolute BA Study
NCT01822041
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
ARN-509
Sponsor
Aragon Pharmaceuticals, Inc.